1894sek
-3,1 %
Date:2025-06-27Time:11:52:50Latest report:Q1-2025List:Small CapTicker:ORX
Market Cap:712 msekEnterprise Value:1 054 msekNet Sales:597,0 msekEarnings:-209,9 msekEmployees:0ISIN:SE0000736415

Ratios

10-year key figure history for Orexo turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Orexo with index and moving average MA50 and MA200.

Stockprice:18,94
MA50:16,23
MA200:15,46
Price/MA200:23,9 %
RSI (14):61,4
Price/MA50:18,1 %

Description

Orexo is a Swedish pharmaceutical company that develops improved medicines based on proprietary formulation technologies and with a focus on meeting major medical needs. In the US market, Orexo commercializes treatments for patients suffering from opioid addiction. Products targeting other therapeutic areas are developed and commercialized worldwide through partners.

Pharmaceuticals